EP0711160A4 - Procede d'inhibition de la replication des virus de l'immunodeficience humaine a l'aide d'azaspirannes substitues - Google Patents

Procede d'inhibition de la replication des virus de l'immunodeficience humaine a l'aide d'azaspirannes substitues

Info

Publication number
EP0711160A4
EP0711160A4 EP94922685A EP94922685A EP0711160A4 EP 0711160 A4 EP0711160 A4 EP 0711160A4 EP 94922685 A EP94922685 A EP 94922685A EP 94922685 A EP94922685 A EP 94922685A EP 0711160 A4 EP0711160 A4 EP 0711160A4
Authority
EP
European Patent Office
Prior art keywords
replication
inhibiting
human immunodeficiency
immunodeficiency viruses
azaspiranes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94922685A
Other languages
German (de)
English (en)
Other versions
EP0711160A1 (fr
Inventor
Alison Mary Badger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0711160A1 publication Critical patent/EP0711160A1/fr
Publication of EP0711160A4 publication Critical patent/EP0711160A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EP94922685A 1993-07-23 1994-07-22 Procede d'inhibition de la replication des virus de l'immunodeficience humaine a l'aide d'azaspirannes substitues Withdrawn EP0711160A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9315340 1993-07-23
GB939315340A GB9315340D0 (en) 1993-07-23 1993-07-23 Methods
PCT/US1994/008276 WO1995003042A1 (fr) 1993-07-23 1994-07-22 Procede d'inhibition de la replication des virus de l'immunodeficience humaine a l'aide d'azaspirannes substitues

Publications (2)

Publication Number Publication Date
EP0711160A1 EP0711160A1 (fr) 1996-05-15
EP0711160A4 true EP0711160A4 (fr) 1998-09-09

Family

ID=10739357

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94922685A Withdrawn EP0711160A4 (fr) 1993-07-23 1994-07-22 Procede d'inhibition de la replication des virus de l'immunodeficience humaine a l'aide d'azaspirannes substitues

Country Status (9)

Country Link
EP (1) EP0711160A4 (fr)
JP (1) JPH09500648A (fr)
CN (1) CN1130871A (fr)
AU (1) AU7370994A (fr)
CA (1) CA2167842A1 (fr)
GB (1) GB9315340D0 (fr)
NZ (1) NZ269991A (fr)
WO (1) WO1995003042A1 (fr)
ZA (1) ZA945418B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9315351D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315306D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
BR9601909A (pt) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato
CZ367598A3 (cs) * 1996-05-17 1999-05-12 Anormed Inc. Použití substituovaného azaspiranu

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014462A1 (fr) * 1991-02-19 1992-09-03 Smithkline Beecham Corporation Inhibiteurs de cytokines
WO1993014760A2 (fr) * 1992-01-28 1993-08-05 Smithkline Beecham Corporation Procedes
WO1993015735A1 (fr) * 1992-01-28 1993-08-19 Smithkline Beecham Corporation Procede (non descriptif) de retardement du sida chez des sujets contamines par le vih par administration de composes d'azaspirane substitue
WO1995003048A1 (fr) * 1993-07-23 1995-02-02 Smithkline Beecham Corporation Azaspiranes anti-hiv
WO1995003049A1 (fr) * 1993-07-23 1995-02-02 Smithkline Beecham Corporation Procedes de traitement du vih au moyen d'azaspiranes
WO1995003041A1 (fr) * 1993-07-23 1995-02-02 Smithkline Beecham Corporation Procede d'inhibition de la production de virus de l'immunodeficience chez l'homme au moyen d'azaspiranes substitues

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014462A1 (fr) * 1991-02-19 1992-09-03 Smithkline Beecham Corporation Inhibiteurs de cytokines
WO1993014760A2 (fr) * 1992-01-28 1993-08-05 Smithkline Beecham Corporation Procedes
WO1993015735A1 (fr) * 1992-01-28 1993-08-19 Smithkline Beecham Corporation Procede (non descriptif) de retardement du sida chez des sujets contamines par le vih par administration de composes d'azaspirane substitue
WO1995003048A1 (fr) * 1993-07-23 1995-02-02 Smithkline Beecham Corporation Azaspiranes anti-hiv
WO1995003049A1 (fr) * 1993-07-23 1995-02-02 Smithkline Beecham Corporation Procedes de traitement du vih au moyen d'azaspiranes
WO1995003041A1 (fr) * 1993-07-23 1995-02-02 Smithkline Beecham Corporation Procede d'inhibition de la production de virus de l'immunodeficience chez l'homme au moyen d'azaspiranes substitues

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BADGER A M ET AL: "ANTIARTHRITIC AND SUPPRESSOR CELL INDUCING ACTIVITY OF AZASPIRANES:STRUCTURE-FUNCTION RELATIONSHIPS OF A NOVEL CLASS OF IMMUNOMODULATORY AGENTS", JOURNAL OF MEDICINAL CHEMISTRY, vol. 33, no. 11, November 1990 (1990-11-01), pages 2963 - 2970, XP000605424 *
P.S. SARIN ET AL.: "INHIBITION OF HTLV-III REPLICATION IN CELL CULTURES", NATO ASI SER., SER. A, vol. 120, 1986, pages 329 - 42, XP002069579 *
S. GOODMAN: "THERAPEUTIC EFFECTS OF ORGANIC GERMANIUM", MEDICAL HYPOTHESES, vol. 26, 1988, pages 207 - 215, XP002069578 *
See also references of WO9503042A1 *

Also Published As

Publication number Publication date
ZA945418B (en) 1995-05-10
WO1995003042A1 (fr) 1995-02-02
CN1130871A (zh) 1996-09-11
JPH09500648A (ja) 1997-01-21
GB9315340D0 (en) 1993-09-08
NZ269991A (en) 1999-07-29
AU7370994A (en) 1995-02-20
EP0711160A1 (fr) 1996-05-15
CA2167842A1 (fr) 1995-02-02

Similar Documents

Publication Publication Date Title
HU9401580D0 (en) Method for the preparation and popification of alphia - interferon
GB9309397D0 (en) Laser treatment
GR3022484T3 (en) Osteosynthesis aid.
HU9202477D0 (en) Compounds against hiv and relative viruses and method for producing them
AU6774294A (en) Methods of preventing viral replication
ZA936592B (en) Nutrition for persons infected with human immunodeficiency virus
MX9100352A (es) Procedimiento para la recuperacion de valores de titanio
GB2272394B (en) Scalpel
IL109891A0 (en) Virus resistant plants
KR970000398B1 (en) Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane
IL109437A0 (en) 2-Amino-4-quinolyldihydropyridines, processes for their preparation and their use
GR3026571T3 (en) Preparation of 2-H-heptafluoropropane.
EP0622384A3 (fr) Procédé de préparation de polymères-polyesterols.
HRP931016A2 (en) Thienothiazin derivatives, process for the preparation and application thereof
EP0711160A4 (fr) Procede d'inhibition de la replication des virus de l'immunodeficience humaine a l'aide d'azaspirannes substitues
ZA947384B (en) Process for the preparation of a modified polytetrafluoroethylene and its use.
EP0713391A4 (fr) Procede d'inhibition de la production de virus de l'immunodeficience chez l'homme au moyen d'azaspiranes substitues
EP0635482A3 (fr) Procédé pour la préparation de polyfluoronitrobenzènes.
ZA942809B (en) Treatment
GB9410256D0 (en) Process for the preparation of co-polymers
GB9301928D0 (en) Footrest
EP0717622A4 (fr) Procedes de traitement du vih au moyen d'azaspiranes
GR3024856T3 (en) Process for the preparation of dichloroacetylchloride.
EP0621264A3 (fr) Procédé de préparation de 4-alkanoylaryl-benzyléthers.
EP0635481A3 (fr) Procédé pour la préparation de fluoronitrobenzènes.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960201

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: SI PAYMENT 960201

RAX Requested extension states of the european patent have changed

Free format text: SI PAYMENT 960201

A4 Supplementary search report drawn up and despatched

Effective date: 19980722

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19981009

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1012280

Country of ref document: HK